SEC Contract Filing

Filing Date: 2023-05-31

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>cosm_ex101.htm
<DESCRIPTION>BINDING LETTER
<TEXT>
<html><head><title>cosm_ex101.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 10.1</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><u>BINDING</u></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><u>LETTER OF INTENT (LOI)</u></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">This Letter of Intent (&#8220;LOI&#8221;) sets forth the terms and conditions for a proposed acquisition and financing by <strong>Cosmos Health Inc.</strong> (&#8220;<strong>Cosmos</strong>&#8221;), a corporation organized under the laws of the State of Nevada, with Company I.R.S number (27-0611758),located at 141 West Jackson Boulevard, Suite 4236, Chicago, IL 60604, of <strong>Docpharm Gmbh. </strong>(the &#8220;<strong>Company</strong>&#8221; or &#8220;docpharm<sup style="vertical-align:super">&#174;</sup>&#8221;), a company organized under the laws of Germany with Company registration number HRB 782055, located at Borsigstrasse 3, 71263, Weil der Stadt, Germany.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The Company is an ISO certified and licensed under GDP (Good Distribution Practices) pharmaceutical company that imports and distributes medicines, pharmaceutical products and medical devices. Moreover, the Company holds a wholesaler license issued from the local government of Baden W&#252;rttemberg and owns a substantial number of medicine and medical device licenses, that enable the company to be engaged in the distribution business of pharmaceutical products within Germany (all licenses and related permits and authorizations, collectively, the &#8220;<strong>Assets</strong>&#8221;).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">This LOI is intended to be a binding agreement setting out the basic terms of the acquisition and financing and shall be superseded by a definitive Sales and Purchase Agreement (&#8220;<strong>SPA</strong>&#8221;) and related transaction documents as described herein (&#8220;<strong>Transaction Documents</strong>&#8221;) entered by the parties governing the Transaction (as defined below).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font-size:10pt;text-align:left;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:15%;vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Proposed Transaction:&nbsp;&nbsp;&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">Cosmos shall, directly or indirectly through a subsidiary, acquire all of the outstanding shares of capital stock in the Company together with all of its Assets (the &#8220;<strong>Shares</strong>&#8221;), free and clear of all encumbrances, in exchange for cash, payable (or issued) to the Company or other controlling entity or person (the &#8220;<strong>Transaction</strong>&#8221;). Cosmos shall further provide funds for financing the growth and working capital of the company according to the business-plan, which has to be agreed among both parties. </p></td></tr> <tr style="height:15px"> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p></td></tr> <tr style="height:15px"> <td style="vertical-align:top;"> <p style="font-size:10pt;font-family:times new roman;margin:0px">Due Diligence:&nbsp;</p></td> <td> <p style="font-size:10pt;font-family:times new roman;text-align:justify;margin:0px">Further to the documents and information already shared with Cosmos following the Confidentiality Agreement signed by the Parties and after the date of this LOI, the Company&#8217;s management shall allow Cosmos and its advisors full access to the Company&#8217;s facilities, records, key employees and advisors for the purpose of completing Cosmos&#8217;s due diligence review. The due diligence investigation will include, but is not limited to, a complete review of the Company's financial, legal, tax, environmental, intellectual property and labor records and agreements, and any other matters as Cosmos&#8217;s accountants, tax and legal counsel, and other advisors deem necessary.&nbsp; For the avoidance of doubt, the due diligence might include a&nbsp; PCAOB audit of the Company.</p></td></tr></table></p> <p style="margin:0px"></p> <p style="margin: 0px"></p> <p style="margin:0px"> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;&nbsp;&nbsp;&nbsp;</p> <p style="margin:0px"> <p style="margin:0px"> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px